U.S. markets closed

Lexington Biosciences, Inc. (LXGTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.07700.0000 (0.00%)
At close: 10:24AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0770
Open0.0920
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0770 - 0.0920
52 Week Range0.0102 - 0.3999
Volume1,811
Avg. Volume21,488
Market Cap291,585
Beta (5Y Monthly)1.01
PE Ratio (TTM)N/A
EPS (TTM)-0.0580
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    Lexington Biosciences Announces Appointment of CEO

    Lexington Biosciences, Inc. (CSE:LNB) (the “Company” or “Lexington”) is pleased to announce the appointment of Donald McInnes as chief executive officer of the Company, filing the vacancy left by the resignation of Eric Willis. Since 1993, Mr. McInnes has been the founder, president and a director of a number of public natural resource companies.